Zoltán Csanádi

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Circulating ACE2 activity correlates with cardiovascular disease development

Úri Katalin, Miklós Fagyas, Attila Kertész et al. · Journal of the Renin-Angiotensin-Aldosterone System · 2016 · 127 citations · Full text

Hypertension, Vascular Disease, Heart Failure +22

Re-Mind the Gap! Insertion – Deletion Data Reveal Neglected Phylogenetic Potential of the Nuclear Ribosomal Internal Transcribed Spacer (ITS) of Fungi

László G. Nagy, Sándor Kocsubé́, Zoltán Csanádi et al. · PLoS ONE · 2012 · 116 citations · Full text

Genetics, Genomics, Indel-rich Phylogenetic Markers +17

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure

Úri Katalin, Miklós Fagyas, Ivetta Mányiné Siket et al. · PLoS ONE · 2014 · 94 citations · Full text

Transcranial Measurement of Cerebral Microembolic Signals During Pulmonary Vein Isolation

Edina Nagy-Baló, Diana Ţînţ, Marcell Clemens et al. · Circulation Arrhythmia and Electrophysiology · 2013 · 53 citations